These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38417728)

  • 1. High loading of lipophilic compounds in mesoporous silica for improved solubility and dissolution performance.
    Benedikt Brenner M; Wüst M; Kuentz M; Wagner KG
    Int J Pharm; 2024 Apr; 654():123946. PubMed ID: 38417728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo.
    Guan H; Wang M; Yu S; Wang C; Chen Q; Chen Y; Zhang W; Fan J
    J Pharm Sci; 2024 Oct; 113(10):3045-3053. PubMed ID: 39094942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant properties of probucol released from mesoporous silica.
    Lau M; Giri K; Garcia-Bennett AE
    Eur J Pharm Sci; 2019 Oct; 138():105038. PubMed ID: 31398394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation.
    Price DJ; Nair A; Becker-Baldus J; Glaubitz C; Kuentz M; Dressman J; Saal C
    Eur J Pharm Sci; 2020 Jan; 141():105113. PubMed ID: 31655207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
    McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
    J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
    Baumgartner A; Planinšek O
    Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization capacity and release kinetics.
    Šoltys M; Zůza D; Boleslavská T; Machač Akhlasová S; Balouch M; Kovačík P; Beránek J; Škalko-Basnet N; Flaten GE; Štěpánek F
    Int J Pharm; 2021 Sep; 607():120982. PubMed ID: 34371148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.
    Zarinwall A; Maurer V; Pierick J; Oldhues VM; Porsiel JC; Finke JH; Garnweitner G
    Drug Deliv; 2022 Dec; 29(1):2086-2099. PubMed ID: 35838584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailability.
    Zhang Z; Quan G; Wu Q; Zhou C; Li F; Bai X; Li G; Pan X; Wu C
    Eur J Pharm Biopharm; 2015 May; 92():28-31. PubMed ID: 25720818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.